ClinicalTrials.gg
CompletedNCT03029962Girl2GirlUpdated Mar 16, 2021

Girl2Girl: Harnessing Text Messaging to Reduce Teenage Pregnancy Among LGB Girls

An interventional study of Girl2Girl in Teenage Pregnancy, sponsored by Center for Innovative Public Health Research. Completed at 1 site in United States. Open to female participants aged 14 Years to 18 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-03-16.

Sponsored by Center for Innovative Public Health Research · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Oct 2016, registered Jan 2017).
Phase
Not applicable
Study type
Interventional
Enrollment
948
Allocation
Randomized
Ages
14 Years to 18 Years
Sex
Female
01

Study summary

The purpose of this study is to finalize and rigorously evaluate Girl2Girl, a novel text messaging-based teenage pregnancy prevention (TPP) program designed specifically for LGB women ages 14-18 years, nation-wide. The guiding theoretical model is the Information-Motivation-Behavioral Skills (IMB) Model, which has been used extensively and is associated with increases in TPP behavior.

Read the detailed description

An estimated one in four teen women will become pregnant by the time she is 20 years of age. That said, significant disparity in rates exist for lesbian, gay, bisexual and other sexual minority women (LGB) versus non-LGB teen women: Research suggests that lesbian and bisexual teen women are between two and four times more likely to report having been pregnant than teen women who identified as exclusively heterosexual. Despite this compelling evidence that lesbian and bisexual adolescent women are at risk for teen pregnancy, programs tailored to the unique needs of adolescent LGB women are nonexistent. Evidence-based teen pregnancy prevention (TPP) programs targeting LGB teen women are urgently needed.

The Girl2Girl intervention text messaging-based TPP program designed specifically for LGB women ages 14-18 years, nation-wide. The investigators will test the intervention in a randomized control trial (RCT) of 840 LGB teenage women randomly assigned to either the intervention (n = 420) or control (n = 420) arms. Our primary efficacy outcome measures, measured at 12-months post-intervention, will be: (a) abstinence from penile-vaginal sex; (b) condom use during penile-vaginal sex, (c) use of other birth control methods during penile-vaginal sex, and (d) pregnancy.

If effective, Girl2Girl has promise to be quickly and cost-effectively implemented to scale to help to curb the spread of teenage pregnancy among women who identify as LGB.

02

Conditions studied

  • Teenage Pregnancy

Keywords

  • Teenage Pregnancy Prevention
  • LGB Girls
  • Text-Messaging
  • Information-Motivation-Behavioral Skills(IMB)Model
03

In context

Lead sponsor

Center for Innovative Public Health Research is the lead sponsor of 13 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
14 Years to 18 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • endorse a non-heterosexual sexual identity (i.e., lesbian/gay, bisexual, queer, questioning, unsure);
  • be cisgender (i.e., be assigned a female sex at birth and endorse a female gender identity);
  • be aged 14-18;
  • in high school or equivalent (including those who did not finish school/dropped out);
  • be English speaking;
  • be exclusive owners of a cell phone with an unlimited text messaging plan;
  • have used text messaging for at least six months;
  • intend to have the same cell number for the next six months; and,
  • be able to provide informed assent, including an acceptable score for "capacity to consent" and the self-safety assessment.

Exclusion criteria

Exclusion Criteria:

  • not having the capacity to assent
  • not passing the self-safety assessment
  • previously participating in another study activity (with the exception of the baseline and intervention end survey pilot tests)
  • knowing someone who is already enrolled in the program
  • non-cisgender
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
948 participants (actual)

Study arms

  • Experimental
    Experimental: Girl2Girl

    Girl2Girl is a 7-week teenage pregnancy prevention program delivered daily via text messaging to 14-18 year old females who self-identify as lesbian, bisexual, gay, or other sexual minority. In addition to program content, participants are paired with another participant (i.e., a Text Buddy) with whom they can text throughout the program to provide support; and an on-demand advice line, Girl2Genie, which shares information about sex, relationships, and the lesbian, gay, bisexual, transgender (LGBT) community.

    Behavioral: Girl2Girl

  • No intervention
    No Intervention: Health Lifestyle

    The attention-matched control arm message content consists of information publicly available online related to living a healthy lifestyle. Content discussed includes: nutrition and sleep hygiene, self-esteem and body image, bullying, and drugs and alcohol. The control arm is 7-weeks in length (Week 7 is a review booster) and is delivered via text messaging. Messages are didactic and not tailored to user sexual experience. Additionally, the Text Buddy and G2Genie intervention program components are not available.

Interventions

  • BehavioralGirl2Girl

    Girl2Girl is a text messaging-based teenage pregnancy prevention program specifically for 14-18 year old LGB adolescent females. Content is guided by the Information-Motivation-Behavioral Skills (IMB) model and focuses on: HIV information, motivations to engage in HIV preventive behavior, communication skills, behavioral skills (e.g., using a condom; HIV testing); and healthy/unhealthy relationships. Behavioral skills content is reinforced using brief online videos. The intervention is 7 weeks long. A "booster" is delivered 12-weeks post-intervention end and reviews the topics covered in the intervention. Girl2Girl content is tailored based upon sexual experience (i.e., whether one is abstinent or sexually active) and whether one is same-sex or dually attracted.

06

What researchers measure

Primary outcomes

  1. Number of protected penile-vaginal sex acts

    The relative difference of protected penile-vaginal sex acts in the intervention versus control group at 12-months post-intervention

    Time frame: Post-intervention (about 20 weeks after randomization)

  2. Number of participants who used other birth control methods

    The relative difference of teens who used birth control methods other than condoms (e.g., the pill, the patch) in the intervention versus control group at 12-months post-intervention

    Time frame: Post-intervention (about 20 weeks after randomization)

  3. Number of participants who abstained from penile-vaginal sex

    The relative difference of abstinence (not engaging in vaginal sex) in the intervention versus control group at 12-months post-intervention

    Time frame: Post-intervention (about 20 weeks after randomization)

Secondary outcomes

  1. Number of penile-vaginal sex acts during which a condom was used

    The relative difference of protected penile-vaginal sex acts in the intervention versus control group at immediate post-intervention end, 3-, 6-, and 9-months post-intervention

    Time frame: immediate post-intervention end, 3-, 6-, 9-months post-intervention

  2. Number of participants who used other birth control methods

    The relative difference of teens who used birth control methods other than condoms (e.g., the pill, the patch) during penile-vaginal sex acts in the intervention versus control group at immediate post-intervention end, 3-, 6-, and 9-months post-intervention

    Time frame: immediate post-intervention end, 3-, 6-, 9-months post-intervention

  3. Number of participants who abstained from penile-vaginal sex

    The relative difference of abstinence (not engaging vaginal sex) in the intervention versus control group at immediate post-intervention end, 3-, 6-, and 9-months post-intervention

    Time frame: immediate post-intervention end, 3-, 6-, 9-months post-intervention

  4. Pregnancy

    The percent of teens who have been pregnant since the beginning of the RCT in the intervention versus control group

    Time frame: Across the 12 months post-intervention

Other outcomes

  1. Intentions to use condoms

    The percent of teens who intend to use condoms if they have penile-vaginal sex in the next year in the intervention versus control group

    Time frame: immediate post-intervention end, 3-, 6-, 9-, and 12-months post-intervention

  2. Intentions to use birth control other than condoms

    The percent of teens who intend to use birth control methods other than condoms in the next year for the intervention versus control group

    Time frame: immediate post-intervention end, 3-, 6-, 9-, and 12-months post-intervention

07

Study locations

1 site
  • Center for Innovative Public Health Research
    San Clemente, California 92672-6745, United States
08

References and documents

Publications

  • Ybarra ML, Parrilla JS, Wolowic J, Rosario M, Goodenow C, Saewyc E. A National, Qualitative Study of Sexual Decision Making by Teenage Girls who are Lesbian, Gay, Bisexual, or who have Another Nonheterosexual Identity. J Pediatr. 2020 Feb;217:177-183. doi: 10.1016/j.jpeds.2019.10.038. Epub 2019 Dec 13. PubMed 31843216 ↗
  • Doull M, Wolowic J, Saewyc E, Rosario M, Prescott T, Ybarra ML. Why Girls Choose Not to Use Barriers to Prevent Sexually Transmitted Infection During Female-to-Female Sex. J Adolesc Health. 2018 Apr;62(4):411-416. doi: 10.1016/j.jadohealth.2017.10.005. Epub 2017 Dec 28. PubMed 29290373 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 16, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03029962
Lead sponsor
Center for Innovative Public Health Research
Collaborators
The Office of Adolescent Health, HHS, University of British Columbia, City University of New York
Responsible party
Sponsor
First posted
Jan 24, 2017
Start date
Oct 2016
Primary completion
Jan 12, 2020
Completion
Jan 12, 2020
Last update
Mar 16, 2021

Study contacts

Michele L Ybarra, PhD
principal investigator · Center for Innovative Public Health Research

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion